InnovAge
INNV
#5514
Rank
A$2.12 B
Marketcap
A$15.65
Share price
4.25%
Change (1 day)
177.01%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2025 (TTM): A$6.46 Million

According to InnovAge's latest financial reports the company's current earnings are A$0.91 Billion. , an increase over its 2024 earnings that were of -A$37.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2025

Annual earnings

Year Earnings Change
2025 A$7.4 M-119.56%
2024 -A$37.87 Million-24.58%
2023 -A$50.22 Million-31.82%
2022 -A$73.65 Million-681.94%
2021 A$12.65 M-388.91%
2020 -A$4.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
A$19.07 B 257,328.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Cocrystal Pharma
COCP
-A$14.17 Million-291.19%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-A$14.92 Million-301.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
A$0.74 B 9,932.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland